Medulloblastoma (MB), the most common malignant brain tumor of childhood, is classified according to pathomorphologic characteristics in the group of central nervous system embryonal tumors, but both its pathogenesis and biologic behavior remain unknown. In addition, the relationship of MB to other embryonal brain tumors is debated and response to therapy is difficult to predict. The authors report an uncommon case of unfavorable late relapse, local as well as distant, in a 26-year old male patient, who was free of disease and without treatment-related morbidity for fifteen years after combined therapy for pediatric MB.
JenkinD: The radiation treatment of medulloblastoma. J Neurooncol29: 45–54, 1996.
2.
PackerJRGoldveinJNicholsonHS: Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol17: 2127–2136, 1999.
3.
HabrandJLDe CrevoisierR: Radiation therapy in the management of childhood brain tumors. Childs Nerv Syst17: 121–133, 2001.
4.
PackerRJSuttonLNEltermanR: Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg81: 690–698, 1994.
5.
BaileyCCGnekowAWellekS: Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol25: 166–78, 1995.
6.
ThomasPRDeutschMKepnerJL: Low-stage medulloblastoma: Final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol18: 3004–11, 2000.
7.
TaylorREBaileyCCRobinsonK: Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol21: 1581–91, 2003.
8.
YaoMSMehtaMPBoyettJM: The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: A phase III study in a high risk patient population. Int J Radiat Oncol Biol Phys38: 469–486, 1997.
9.
InakoshiHKaymoriRTsuchidaE: Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation. Radiat Med21: 37–45, 2003.
10.
MerchantTEWangMHHaidaT: Medulloblastoma: Long term results for patients treated with definitive radiation therapy during the computed tomography era. Int J Radiat Oncol Biol Phys42: 143–146, 1996.
11.
BrownHGKepnerJLPerlmanEJ: “Large Cell/Anaplastic” Medulloblastoma: A Pediatric Oncology Study Group. J Neuropathol Exp Neurol59: 857–865, 2000.
12.
HershatterBWHalperinECCoxEB: Medulloblastoma: The Duke experience. Int J Radiat Oncol Biol Phys12: 1829–1837, 1986.
13.
ErfurthEMBulowBMikoczyZ: Is there an increase in second brain tumours after surgery and irradiation for a pituitary tumour?Clin Endocrinol55: 613–616, 2001.
EvansAEJenkinRDTSpostoR: The Treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisone. J Neurosurg72: 572–582, 1990.
16.
TaitDMThornton-JonesHBloomHJG: Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Pediatric Oncology (SIOP I). Eur J Cancer26: 464–469, 1990.
17.
HughesENShillitoJSallanSE: Medulloblastoma at the Joint Center for Radiation Therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival. Cancer61: 1992–1998, 1988.
18.
ZeltzerPMBoyettJMFinlayJL: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Chidren's Cancer Group 921 randomized phase III study. J Clin Oncol17: 832–845, 1999.
19.
PomeroySLTamayoPGaasenbeekM: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature415: 436–442, 2002.
20.
ChopraABrownKMRoodBR: The use of gene expression analysis to gain insights into signaling mechanisms of metastatic medulloblastoma. Pediatr Neurosurg39: 68–74, 2003.
